David Matthews has been named chief financial officer at Med BioGene, the Vancouver, BC-based firm said last week.
Matthews served previously as a director for BMO Capital, a subsidiary of the Bank of Montreal. Prior to that, he was the managing director of Aspreva Pharmaceuticals, the European subsidiary of Aspreva Pharmaceuticals, now Galenica Group. Matthews also was CFO of StressGen Biotechnologies and Allelix Biopharmaceuticals.
Richard Sauer has been promoted to chief financial officer at Network Engineering Technologies. He previously was controller and senior director of materials management at Roche NimbleGen.
Following the retirement of Steven Gutman as director of the US Food and Drug Administration's Office of In Vitro Diagnostics, Don St. Pierre is serving as the acting director of the division until a permanent director is hired.
OIVD has been interviewing candidates and a permanent director is expected to be hired by this spring, according to Alberto Gutierrez, deputy office director of new product evaluation at OIVD, who spoke at meeting of the HHS Secretary's Advisory Committee on Genetics, Health, and Society last week in Washington, DC.
The International Society for Computational Biology has named Webb Miller, of Pennsylvania State University, the winner of the Senior Scientist Award for 2009; and Trey Ideker, of the University of California, San Diego, the winner of the 2009 Overton Prize.
The senior scientist award recognizes members of the computational biology community who have made major contributions to research, education, and service, and the Overton Prize recognizes outstanding accomplishment by an early-career or mid-career scientist involved in computational biology.